Expansion Vision

Diabetic &
Insulin Division.

Exclusively focused on insulin products and diabetic healthcare solutions. A long-term business vision to expand into specialized and life-saving healthcare segments.

The Healthcare Challenge

101+ Million Diabetic Patients.

India currently faces a rapidly increasing diabetes burden, making diabetic care one of the country's most critical healthcare priorities.

Key Market Drivers:

Changing lifestyles
Sedentary habits
Dietary changes
Genetic predisposition
Targeted Portfolio Trajectory

Demand Trajectory Projections

Strategic market penetration mapping across specialized core validation units.

IP 30/70
IP 50/50
Isophane
Soluble

Focus of the New Division

The upcoming segment dedicates its structural infrastructure entirely to specialized therapies, high-volume operational targets, and manufacturing compliance.

Primary Core Target

Insulin Products Area

Strategic deployment exclusively centered on high-volume insulin batches, manufacturing scalability validation, advanced glucose control management delivery, and dedicated institutional supplies.

🧪

Business Vision & Growth Strategy

Enhance overall growth potential
Expand nationwide opportunities
Strengthen institutional partnerships
Increase operational & market value
Support sustainable business expansion